Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The hyperinsulinemic-euglycemic infusion, commonly known as the 'clamp' technique, is a clinical procedure used to measure insulin sensitivity and metabolic response. In the context of research at the University of Missouri-Columbia, this intervention is utilized as a mechanistic tool to study the physiological effects of insulin in individuals with obesity, specifically focusing on its role in modulating blood flow and sympathetic nervous system activity. The procedure involves the simultaneous intravenous administration of insulin to raise systemic insulin levels (hyperinsulinemia) and glucose (dextrose) at a variable rate to maintain normal blood sugar levels (euglycemia). By titrating the glucose infusion rate to match the rate of insulin-stimulated glucose uptake, researchers can quantify the degree of insulin resistance. This specific study (NCT01142635) also investigated how these responses are influenced by endothelin-1 (ET-1) signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on insulin + glucose (University of Missouri).